Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference14 articles.
1. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis;Mehra;Lancet,2020
2. Remdesivir for the Treatment of Covid-19 - Preliminary Report;Beigel;N Engl J Med,2020
3. Development of the quinolones;Andersson;J Antimicrob Chemother,2003
4. Mode of action of fluoroquinolones;Hooper;Drugs,1999
5. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America;Metlay;Am J Respir Crit Care Med,2019
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. H. Pylori Treatment in the COVID-19 Era. What Have We Learned So Far?;Current Gastroenterology Reports;2024-02-02
2. Improved ciprofloxacin removal by a novel organohalloysite obtained by phenylphosphonic acid intercalation;Journal of Environmental Chemical Engineering;2024-02
3. Cardiotoxic Drugs Used in the Treatment of COVID-19;Antibiotics and Chemotherapy;2024-01-16
4. Genome sequencing of Porostereum spadiceum to study the degradation of levofloxacin;Ecotoxicology and Environmental Safety;2024-01
5. Response surface optimised photocatalytic degradation and quantitation of repurposed COVID-19 antibiotic pollutants in wastewaters; towards greenness and whiteness perspectives;Environmental Chemistry;2023-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3